首页> 外文期刊>Autopsy & case reports. >Clozapine-induced hypersensitivity myocarditis presenting as sudden cardiac death
【24h】

Clozapine-induced hypersensitivity myocarditis presenting as sudden cardiac death

机译:氯氮平诱发的超敏反应性心肌炎,表现为心源性猝死

获取原文
           

摘要

Hypersensitivity myocarditis is a rare but serious adverse effect of clozapine, a commonly used psychiatric drug. We report the case of sudden cardiac death from clozapine-induced hypersensitivity myocarditis diagnosed at autopsy. A 54-year-old Caucasian male on clozapine therapy for bipolar disorder presented with a sudden onset of shortness of breath. Laboratory studies were significant for elevated N-terminal prohormone of brain natriuretic peptide. During his hospital stay, the patient died of sudden cardiac arrest from ventricular tachycardia. The autopsy revealed hypersensitivity myocarditis, which usually occurs in the first 4 weeks after the initiation of clozapine. A 4-week monitoring protocol, including laboratory assessment of troponin and C-reactive protein, may assist in the early diagnosis of this potentially fatal condition.
机译:超敏反应性心肌炎是一种常用的精神科药物氯氮平罕见但严重的不良反应。我们报告了在尸检中诊断为氯氮平诱发的超敏性心肌炎而导致心脏猝死的病例。一名接受氯氮平双相情感障碍治疗的54岁高加索男性,突然出现呼吸急促。实验室研究对于脑利钠肽N端激素水平升高具有重要意义。在住院期间,该患者因室性心动过速突然心脏骤停死亡。尸检显示过敏性心肌炎,通常发生在氯氮平起始后的前4周。为期4周的监测协议,包括对肌钙蛋白和C反应蛋白的实验室评估,可能有助于早期诊断这种潜在的致命疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号